Dexmedetomidine as an Adjuvant to Bupivacaine in ultrasound-guided thoracic paravertebral block for breast cancer surgeries : Efficacy of two different doses / Ramy Fawzy Mahmoud ; Supervised Neamat Ibrahim , SaharAbdelhalim , Abeer Ahmed
Material type:
- استخدام عقار"الديكسميديتوميدين" كعقار مساعد ل"البوبيفاكين" في احصار جنبي الفقار الصدربأستخدام السونار في عمليات سرطان الثدي : مقارنة بين جرعتين مختلفتين [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
---|---|---|---|---|---|---|---|
![]() |
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.01.M.Sc.2015.Ra.D (Browse shelf(Opens below)) | Not for loan | 01010110068878000 | ||
![]() |
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.01.M.Sc.2015.Ra.D (Browse shelf(Opens below)) | 68878.CD | Not for loan | 01020110068878000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Anaesthesia
This study was conducted on 90 patients divided equally into 3 groups receiving either dexmedetomidine 0.5 og/kg (groupBD0.5) or dexmedetomidine 1 og/kg (groupBD1) added to Bupivacaine 0.25% or Bupivacaine 0.25% alone (group B) in TPVB with general anaesthesia in females undergoing MRM. Postoperative pain scores and opioid requirements were significantly lower in the first 24 hours in both groups BD0.5 and group BD1
Issued also as CD
There are no comments on this title.